In a study involving GMB tumor cells, it was demonstrated that the KRAS/ERK signaling pathway regulates the overexpression of CD44 in response to radiation by downregulating micro-RNA expression in GBM cells [142]. This evidence concerns the gene CD44 and neoplasm.